AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

Matthew Eyles
Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Centers Appeal Loss in California Medicaid Lawsuit

Michelle Baass headshot
Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

Jefferson Health building
An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More Drugmakers Owe 340B Provider Repayments, HRSA Audits Find

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Jazz Pharmaceuticals Is 25th Drugmaker to Implement Contract Pharmacy Restrictions

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.
Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Legislature Passes 27th State Restriction on PBM 340B Discrimination

california capitol building
The California Senate recently cleared a bill that would make it the 27th state with a law protecting against PBM discriminatory reimbursement to 340B entities.
The California Senate recently cleared a bill to bar pharmacy benefit manager (PBM) alleged discrimination against 340B covered entities and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Coming Major GOP Healthcare Package Includes 340B Medicaid Provisions

The House Appropriations Committee approved the Labor, Health and Human Services, Education and Related Agencies Appropriations Act on July 10.
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Allows Immediate 340B Enrollment in Florida Due to Hurricane

HRSA updated 340B enrollment eligibility guidelines in Florida in response to a public health emergency for Hurricane Idalia.
Eligible covered entities in Florida may enroll in the 340B program immediately rather than having to wait for the next [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As CMS Extends Comment Period on 340B Repayments, Hospitals Urge Changes

CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
While federal regulators recently extended the comment period on a proposed lump sum repayment plan for hospitals Illegally underpaid for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider Groups Oppose 340B Provisions in Committee Chair’s Drug Shortage Bill

House E&C wordmark
Provider groups criticized draft legislation to address drug shortages from the House Energy and Commerce Committee.
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live